EMR Quantitative Stock Analysis

Emerson Electric (EMR) has been rated 87% by Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy for low-volatility stocks with strong momentum and high net payout yields. This score indicates "some interest" for the large-cap growth stock, aligning with the strategy's core principle of low volatility while showing neutral performance on momentum and net payout yield metrics. The assessment highlights EMR's suitability for a conservative factor investing approach, despite mixed individual factor performance.

Analysis

Emerson Electric Co. (EMR) receives an 87% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy favoring low-volatility stocks with strong momentum and high net payout yields. This score indicates a moderate level of interest from the model, as it surpasses the 80% threshold but falls short of the 90% mark for strong interest. EMR, a large-cap growth stock, aligns with the core tenet of the strategy by passing the criteria for low volatility (Standard Deviation) and market capitalization. However, the analysis reveals a more nuanced picture, as the stock scores a 'Neutral' rating on both 'Twelve Minus One Momentum' and 'Net Payout Yield', suggesting it does not currently exhibit strength in these specific factors. Critically, despite the high overall score, the stock is marked as a 'FAIL' on the 'FINAL RANK' in the summary table, indicating it may not pass a key, non-disclosed filter within the strategy's final screening process, creating a significant contradiction that warrants caution.

Key Decisions for Investors

• Investors following low-volatility factor strategies may find EMR's profile partially attractive due to its low standard deviation, but should be cautious given its neutral momentum and net payout yield metrics.
• The explicit 'FAIL' on the 'FINAL RANK' despite a high 87% score is a major red flag that requires further due diligence to understand the specific disqualifying criterion before initiating or adding to a position.
• Given the conflicting signals, a 'hold' stance or placing EMR on a watchlist may be more prudent than initiating a new long position until there is either an improvement in momentum and yield factors or clarification on the final rank failure.